Skip to content

Femoral nerve block combined with stellate ganglion block can reduce tourniquet reaction in total knee arthroplasty

Femoral nerve block combined with stellate ganglion block can reduce tourniquet reaction in total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082342
Enrollment
Unknown
Registered
2024-03-27
Start date
2024-03-27
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedic anesthesia

Interventions

Stellate ganglion block and Modified femoral nerve block:Stellate ganglion block
Modified femoral nerve block:no

Sponsors

The Second Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: A total of 72 patients who underwent total knee arthroplasty between March and May of the 2024 were reviewed and approved by the Hospital Ethics Committee, and all included patients signed an informed consent form. 1. Age 40-702. Asa Class I-III 3. Patients with anesthesia time > 45 min 4. At least 72 hours in hospital after surgery. Patients undergoing elective total knee arthroplasty agreed to use nerve blocks and postoperative analgesia pumps.

Exclusion criteria

Exclusion criteria: 1. The inflating time of tourniquet is less than 45 min or more than 150 min. 2. Previous history of neurological and psychiatric disorders: brain injury, seizures, epilepsy, intracranial hypertension, cerebrovascular accident history; Or schizophrenia, mania, long-term use of psychotropic drugs, cognitive impairment history, etc. , can not read, understand and communicate 3. History of allergy to local anesthetics, skin infection at the site of puncture, or contraindications to concurrent block anesthesia. 4. Complicated with severe primary diseases such as lung, liver, kidney, cardiovascular and hematopoietic system. 5. ASA grade IV or higher 6. Bleeding Tendency or Coagulopathy.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;Systolic blood pressure;Heart rate;

Secondary

MeasureTime frame
Operation Time;Anesthesia time;postoperative opioid consumption;The amount of liquid in and out;intraoperative esmolol consumption;intraoperative urapidil consumption;Time spent in recovery room;Postoperative Recovery Index;Highest Numerical Rating Scale score;Average Numerical Rating Scale score; PCA pressing frequency;sleep disturbance;Changes in inflammatory markers;Adverse reactions;POCD Incidence;Patient satisfaction;Physician satisfaction;Effective time and success rate;

Countries

China

Contacts

Public ContactLI QI

The Second Hospital of Jiaxing

532987216@qq.com+86 159 5736 2573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026